For more than 125 years, MSD, a leading global biopharmaceutical company, has been inventing for life, bringing forward medicines and vaccines for the world’s most challenging diseases.

About MSD

MSD is a trade name of Merck & Co. Inc., with headquarters in Kenilworth, N.J., U.S.A. Through our prescription medicines, vaccines, biologic therapies and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching policies, programs and partnerships.

Today, MSD continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world – including cancer, cardio-metabolic diseases, emerging animal diseases, lzheimer’s disease and infectious diseases including HIV and Ebola.

MSD has been operating in Russia since 1991 with a focus on delivering innovative medicines and vaccines, cooperation with local manufacturers and leading medical institutions, clinical research programs, as well as medical education and information support. We use our global expertise to contribute to the development of healthcare and pharmaceutical industry in Russia.
MSD Pharmaceuticals LLC.
119021, Russia, Moscow, Timura Frunze Str. 11 build. 1
Tel: +7 495 916 7100
Fax: +7 495 916 7094
RU-NON-00049 as of 02.08.2019

For more information visit